Outcome of patients with dual diagnosis in secondary psychiatric care

Luoto, Kaisa; Koivukangas, Antti; Lassila, Antero; Kampman, Olli

doi:10.3109/08039488.2016.1160149

Cited by 10 publications

(6 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Retention in the treatment network is the cornerstone of improvement in individuals with DD. [80818283] (3) At the end of 6 months, despite similar dropout rates in both groups, there was a significant difference noted in the outcome of psychiatric illness and SUD, i.e., EOS group had better outcome in both psychiatric illness and SUD as compared to the LOS group. This can be because that there was more number of subjects with psychotic disorders or cannabis-induced psychotic disorders in the EOS group and keeping them in the treatment net could have possibly led to better outcome in the EOS group with regard to more number of participants with affective disorders in the LOS group which possibly be having an episodic course with periodic relapses leading to more number of unchanged outcome.…”

Section: Discussionmentioning

confidence: 99%

Age of onset of substance use in patients with dual diagnosis and its association with clinical characteristics, risk behaviors, course, and outcome: A retrospective study

Subodh

Sahoo

Basu

et al. 2019

Indian J Psychiatry

View full text Add to dashboard Cite

Research Question: Do patients with dual diagnosis (DD) with an early initiation of substance use and subsequent early onset substance use disorder (EOS) differ from those with late onset substance use disorder (LOS) regarding characteristics, sex-related risk behaviors, course, and outcome? Objectives: The aim is to study EOS and LOS groups of patients with DD attending a treatment center with regard to clinical characteristics, type of psychiatric disorders, risk behaviors, and short-term outcome. Materials and Methods: Retrospective chart review of patients diagnosed with DD ( n = 307) with regard to the above variables. Diagnoses of both substance use disorders (SUDs) and psychiatric disorders were made by qualified psychiatrists as per the International Classification of Diseases, 10 th revision. Results: Among 307 participants with DD, 100 were in EOS group (onset of SUD before 18 years of age as assessed clinically) and 207 in LOS group. Cannabis as the primary substance was more prevalent in the EOS (30%) than that of the LOS group (12%). Psychotic disorders were more prevalent in the EOS group (41%) followed by mood disorders (30%), while the reverse was true in the LOS group (27.5% and 56.5%, respectively). When compared to the LOS group, the EOS group had higher number of psychiatric admissions, reported higher prevalence of risky sexual behaviors (unprotected sexual intercourse, multiple sexual partners, and history of sexual intercourse with commercial sex workers), showed poorer treatment adherence, and worse outcome regarding both psychiatric disorder and SUD (all differences significant at P < 0.05). Conclusions: DD patients differ significantly based on the age of onset of substance use. These may have therapeutic and management implications.

show abstract

Section: Discussionmentioning

confidence: 99%

Age of onset of substance use in patients with dual diagnosis and its association with clinical characteristics, risk behaviors, course, and outcome: A retrospective study

Subodh

Sahoo

Basu

et al. 2019

Indian J Psychiatry

View full text Add to dashboard Cite

show abstract

“…For the ODS intervention group, the baseline assessment was based on the Cube Method which is an integrated assessment method for comorbid psychiatric and substance use disorders in clinical settings; the method was developed by Kampman and Lassila in the South Ostrobothnia hospital district [ 20 , 21 ]. Systematic assessment helps to target suitable treatment for each patient.…”

Section: Methodsmentioning

confidence: 99%

Behavioral activation versus treatment as usual in naturalistic sample of psychiatric patients with depressive symptoms: a benchmark controlled trial

et al. 2018

Self Cite

View full text Add to dashboard Cite

BackgroundMore systematic use of evidence-based brief therapies is needed in the treatment of depression within psychiatric care. The aim of this study was to explore the impact of behavioral activation therapy (BA) for patients with depressive symptoms in a routine clinical setting of secondary psychiatric care.MethodsThe BA-treated intervention group (n = 242) comprised patients with depressive symptoms (Beck Depression Inventory (BDI) score ≥ 17 at baseline). The control group (n = 205) patients received treatment as usual in the same catchment area. The groups were matched at baseline using BDI and Alcohol Use Disorders Identification Test scores and inpatient/outpatient status. The groups were compared at 6-, 12- and 24-month follow-up points on functional outcome (Global Assessment of Functioning scale), service use, dropout and deaths. The Montgomery–Åsberg Depression Rating Scale was used to assess depressive symptoms in the intervention group.ResultsThe estimated difference in GAF score between intervention and control group patients was significant at 12- and 24-months follow-up points in favor of intervention group (GAF score difference 4.85 points, p = 0.006 and 5.71 points, p = 0.005, respectively; estimate for patient group 2.26, p = 0.036). The rates of dropout, mortality and service use were similar between the groups. Among the intervention group patients, the estimated improvement in MADRS score compared to baseline was statistically significant throughout the follow-up (p < 0.001 at all follow-up points).ConclusionsThe systematic use of BA among secondary psychiatric care depressive patients provides encouraging results despite the patients had various comorbid non-psychotic disorders.Trial registrationClinicalTrials.gov, Identifier NCT02520271, Release Date: 06/27/2015, retrospectively registered.

show abstract

“…Adherence to antidepressants was monitored during the first six weeks of the study using a paper and pencil diary (for more information see [16]). [36,37]. In the present study setting the aim was to identify individuals with marked alcohol use problems with high specificity to obtain motivational interview as an add-on psychosocial treatment.…”

Section: Participantsmentioning

confidence: 99%

Temperament and character profiles are associated with depression outcome in psychiatric secondary care patients with harmful drinking

Paavonen

Luoto

Lassila

et al. 2018

Comprehensive Psychiatry

Self Cite

View full text Add to dashboard Cite

show abstract

Outcome of patients with dual diagnosis in secondary psychiatric care

Abstract: Given our results suggesting a stable level of functioning, patients with DD appear to be well managed within secondary psychiatric care. Attention should be paid to more precise diagnostics of SUDs and to effective use of medication.

Cited by 10 publications

References 36 publications

Age of onset of substance use in patients with dual diagnosis and its association with clinical characteristics, risk behaviors, course, and outcome: A retrospective study

Age of onset of substance use in patients with dual diagnosis and its association with clinical characteristics, risk behaviors, course, and outcome: A retrospective study

Behavioral activation versus treatment as usual in naturalistic sample of psychiatric patients with depressive symptoms: a benchmark controlled trial

Temperament and character profiles are associated with depression outcome in psychiatric secondary care patients with harmful drinking

Contact Info

Product

Resources

About